Mark Gurney
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
Papers in
-
- Extracellular vesicles in disease 7
- Retinoids in leukemia and cellular processes 1
-
- MicroRNA in disease regulation 3
- Co-authors
- Aled Clayton (8 shared papers)Zsuzsanna Tabi (5 shared papers)Jason Webber (5 shared papers)Malcolm D. Mason (2 shared papers)Josephine Salimu (1 shared paper)Saly Al‐Taei (1 shared paper)Lizhou Xu (1 shared paper)Costanza Emanueli (1 shared paper)
- Journals
- Journal of Extracellular Vesicles (3 papers)Nanoscale (1 paper)Oncotarget (1 paper)Scientific Reports (1 paper)The Journal of Infectious Diseases (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Mark Gurney
9 papers receiving 715 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 359
- Molecular Biology 583
- Physiology 25
- Immunology and Allergy 28
- Immunology 100
Countries citing papers authored by Mark Gurney
This map shows the geographic impact of Mark Gurney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gurney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gurney more than expected).
Fields of papers citing papers by Mark Gurney
This network shows the impact of papers produced by Mark Gurney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gurney. The network helps show where Mark Gurney may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Gurney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 225 | |
| 2 | 2017 | 135 | |
| 3 | 2019 | 121 | |
| 4 | 2016 | 109 | |
| 5 | 2016 | 60 | |
| 6 | 2021 | 22 | |
| 7 | 2018 | 21 | |
| 8 | 2019 | 15 | |
| 9 | 2021 | 15 | |
| 10 | 2024 | 0 |
About Mark Gurney
Mark Gurney is a scholar working on Molecular Biology, Cancer Research, Infectious Diseases, Surgery and Small Animals, having authored 10 papers that have together received 723 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (7 papers), MicroRNA in disease regulation (3 papers), Advanced Proteomics Techniques and Applications (1 paper), Prostate Cancer Treatment and Research (1 paper), Antifungal resistance and susceptibility (1 paper), Adenosine and Purinergic Signaling (1 paper), Fungal Infections and Studies (1 paper) and Retinoids in leukemia and cellular processes (1 paper). The work is most often cited by research in Cancer Research (359 citations), Molecular Biology (583 citations), Physiology (25 citations), Immunology and Allergy (28 citations) and Immunology (100 citations). Mark Gurney has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Aled Clayton, Zsuzsanna Tabi, Jason Webber, Malcolm D. Mason, Josephine Salimu, Saly Al‐Taei, Lizhou Xu, Costanza Emanueli, Gianni D. Angelini and Francesca Fiorentino. Their work appears in journals such as Journal of Extracellular Vesicles, Nanoscale, Oncotarget, Scientific Reports and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.